Repro Med Systems (KRMD) Tops Q3 EPS by 3c, provides guidance

Repro Med Systems (NASDAQ: KRMD) reported Q3 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.68 million.

GUIDANCE:

Repro Med Systems sees FY 2024 revenue of $32.75-33.25 million, versus the consensus of $32.172 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Rithm Capital Corp. (RITM) PT Lowered to $14 at UBS on Higher for Longer Rates
• Ross Stores, Inc. (ROST) PT Raised to $239 at UBS on Q2 Earnings Beat